epirubicin has been researched along with Genetic Predisposition in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Geng, R; Guo, W; He, G; Li, J; Liu, R; Liu, X; Qiu, L; Zhao, X; Zhu, X | 1 |
| Cheng, Y; Deng, X; Li, X; Liu, X; Lu, Q; Qin, C; Yang, X; Yin, C; Zhang, X; Zhao, R | 1 |
| Ahmed, MU; Bin Sayeed, MS; Hasnat, A; Hussain, SM; Islam, MS; Parvin, S; Uddin, MM | 1 |
| Dieudonné, AS; Hatse, S; Lambrechts, D; Maggen, C; Neven, P; Paridaens, R; Pettengell, R; Pfeil, AM; Schwenkglenks, M; Szucs, TD; Vulsteke, C; Wildiers, H | 1 |
| Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT | 1 |
| Kordek, R; Kusinska, R; Majsterek, I; Przybylowska-Sygut, K; Stanczyk, M | 1 |
| Huang, SH; Rong, J; Wang, SM; Ye, S; Yun, M; Zheng, ZS | 1 |
| Bai, YL; He, JM; Huo, XQ; Jing, XY; Ma, C; Zhang, B; Zhou, B | 1 |
1 trial(s) available for epirubicin and Genetic Predisposition
| Article | Year |
|---|---|
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2012 |
7 other study(ies) available for epirubicin and Genetic Predisposition
| Article | Year |
|---|---|
Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.
Topics: Aged; Alleles; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aryldialkylphosphatase; Epirubicin; Female; Fluorouracil; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; Linkage Disequilibrium; Male; Middle Aged; Multivariate Analysis; NAD(P)H Dehydrogenase (Quinone); Organoplatinum Compounds; Oxaliplatin; Oxidative Stress; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; Stomach Neoplasms | 2014 |
XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.
Topics: Aged; Alleles; Biomarkers, Pharmacological; China; Disease-Free Survival; DNA-Binding Proteins; Epirubicin; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mitomycin; Polymorphism, Single Nucleotide; Urinary Bladder Neoplasms; X-ray Repair Cross Complementing Protein 1 | 2015 |
Effect of GSTP1 and ABCC4 gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-5-fluorouracil-based chemotherapy in Bangladeshi breast cancer patients.
Topics: Adult; Aged; Bangladesh; Biomarkers, Pharmacological; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Humans; Middle Aged; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide | 2015 |
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.
Topics: Adult; Aged; Alleles; Antibiotics, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Cardiotoxicity; Epirubicin; Female; Genetic Predisposition to Disease; Genotype; Heart Failure; Humans; Middle Aged; Multidrug Resistance-Associated Protein 2; Neoplasm Grading; Neoplasm Staging; Polymorphism, Single Nucleotide; Stroke Volume; Young Adult | 2015 |
Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; DNA Repair; DNA-Binding Proteins; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Immunoenzyme Techniques; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Survival Rate; X-ray Repair Cross Complementing Protein 1 | 2013 |
XRCC1 and ADPRT polymorphisms associated with survival in breast cancer cases treated with chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Middle Aged; Neoplasm Staging; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Prospective Studies; Survival Rate; X-ray Repair Cross Complementing Protein 1 | 2012 |
Predictive role of GSTs on the prognosis of breast cancer patients with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Child; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2012 |